Wall Street Zen upgraded shares of Telos (NASDAQ:TLS - Free Report) from a hold rating to a buy rating in a report issued on Saturday.
A number of other equities research analysts have also recently commented on the stock. Wedbush lifted their price target on shares of Telos from $4.00 to $6.00 and gave the stock an "outperform" rating in a report on Tuesday, August 12th. BMO Capital Markets reiterated a "market perform" rating and issued a $4.50 price objective (up from $2.25) on shares of Telos in a research note on Tuesday, August 12th. Finally, DA Davidson lifted their price objective on shares of Telos from $2.25 to $4.00 and gave the company a "neutral" rating in a research note on Tuesday, August 12th. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $4.88.
Get Our Latest Stock Analysis on TLS
Telos Stock Performance
Shares of NASDAQ:TLS traded up $0.40 during mid-day trading on Friday, reaching $6.03. The company had a trading volume of 2,041,051 shares, compared to its average volume of 2,500,286. The company has a current ratio of 2.65, a quick ratio of 2.55 and a debt-to-equity ratio of 0.06. The firm has a market cap of $438.38 million, a price-to-earnings ratio of -7.83 and a beta of 0.96. The company's 50-day moving average price is $3.21 and its 200-day moving average price is $2.90. Telos has a one year low of $1.83 and a one year high of $6.10.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. NBC Securities Inc. grew its position in shares of Telos by 100,808.3% during the 1st quarter. NBC Securities Inc. now owns 12,109 shares of the company's stock valued at $28,000 after purchasing an additional 12,097 shares in the last quarter. OLD Mission Capital LLC purchased a new position in shares of Telos during the 1st quarter valued at $30,000. AQR Capital Management LLC purchased a new position in shares of Telos during the 1st quarter valued at $39,000. NewEdge Advisors LLC grew its position in shares of Telos by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 17,918 shares of the company's stock valued at $43,000 after purchasing an additional 4,000 shares in the last quarter. Finally, ProShare Advisors LLC grew its position in shares of Telos by 49.1% during the 4th quarter. ProShare Advisors LLC now owns 15,512 shares of the company's stock valued at $53,000 after purchasing an additional 5,105 shares in the last quarter. 62.14% of the stock is currently owned by hedge funds and other institutional investors.
Telos Company Profile
(
Get Free Report)
Telos Corporation, together with its subsidiaries, provides cyber, cloud, and enterprise security solutions worldwide. The company operates in two segments, Security Solutions and Secure Networks. It provides Xacta, a platform for enterprise cyber risk management and security compliance automation; and consulting, assessment and compliance, engineering and evaluation, operations, and penetration testing services.
Featured Stories

Before you consider Telos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telos wasn't on the list.
While Telos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.